Cargando…

Safety and effectiveness of escitalopram in an 8-week open study in Chinese patients with depression and anxiety

BACKGROUND: Anxiety symptoms usually worsen depression and functional impairment. The present study was aimed to evaluate the impact of escitalopram on social function and quality of life in major depressive disorder (MDD) patients with anxiety symptoms. PATIENTS AND METHODS: Adult MDD patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Gang, You, Xiumin, Wang, Xueyi, Xu, Xiufeng, Bai, Ludong, Xie, Jian, Yao, Zhijian, Yi, QiZhong, Ma, Jun, Wang, Jinan, Zhuo, Jianmin, Hu, Cuili
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097511/ https://www.ncbi.nlm.nih.gov/pubmed/30147321 http://dx.doi.org/10.2147/NDT.S164673

Ejemplares similares

Efficacy and tolerability of escitalopram in treatment of major depressive disorder with anxiety symptoms: a 24-week, open-label, prospective study in Chinese population
por: Jiang, Kaida, et al.
Publicado: (2017)

Resistant social anxiety disorder response to Escitalopram
por: Pallanti, Stefano, et al.
Publicado: (2006)

Early Improvement in One Week Predicts the Treatment Response to Escitalopram in Patients with Social Anxiety Disorder: A Preliminary Study
por: Oh, Kang-Seob, et al.
Publicado: (2016)

Efficacy of Buspirone Augmentation of Escitalopram in Patients with Major Depressive Disorder with and without Atypical Features: A Randomized, 8 Week, Multicenter, Open-Label Clinical Trial
por: Shin, Cheolmin, et al.
Publicado: (2020)

PS99. First episode depression and monotherapy with escitalopram: A 16-week, open-label, flexible-dose study
por: Ravindran, Arun V., et al.
Publicado: (2016)

Clinical effectiveness and safety of escitalopram and desvenlafaxine in patients of depression with anxiety: A randomized, open-label controlled trial
por: Maity, Nabakumar, et al.
Publicado: (2014)

Long-term administration of escitalopram in patients with social anxiety disorder in Japan
por: Asakura, Satoshi, et al.
Publicado: (2016)

Effects of 12‐week escitalopram treatment on resting‐state functional connectivity of large‐scale brain networks in major depressive disorder
por: Zhang, Shudong, et al.
Publicado: (2023)

One‐week escitalopram intake alters the excitation–inhibition balance in the healthy female brain
por: Zsido, Rachel G., et al.
Publicado: (2022)

Predicting escitalopram monotherapy response in depression: The role of anterior cingulate cortex
por: Tian, Shui, et al.
Publicado: (2019)

Comparative Efficacy and Safety of Escitalopram versus Desvenlafaxine in Postmenopausal Women with Depression and Anxiety: A Randomized, Open-Label, Comparative Trial
por: Mahajan, Sonia Shinde, et al.
Publicado: (2019)

Safety and efficacy of paliperidone palmitate 1-month formulation in Chinese patients with schizophrenia: a 25-week, open-label, multicenter, Phase IV study
por: Zhao, Jingping, et al.
Publicado: (2017)

Efficacy and safety of generic escitalopram (Lexacure(®)) in patients with major depressive disorder: a 6-week multicenter, randomized, rater-blinded, escitalopram-comparative, non-inferiority study
por: Jeong, Jong-Hyun, et al.
Publicado: (2015)

Escitalopram induced mania
por: Parker, Shubangi, et al.
Publicado: (2007)

Escitalopram in patients with psoriasis
por: Artemieva, M., et al.
Publicado: (2021)

Escitalopram Induced Angioedema
por: Conde, Samantha L, et al.
Publicado: (2022)

The effectiveness and safety of amisulpride in Chinese patients with schizophrenia: An 8‐week, prospective, open‐label, multicenter, single‐arm study
por: Liang, Ying, et al.
Publicado: (2016)

Effects of Escitalopram on Anxiety in Patients with Acute Coronary Syndrome: A Randomized Controlled Trial
por: Kang, Hee-Ju, et al.
Publicado: (2017)

Reproducibility of the Efficacy of Escitalopram in Patients with Major Depression Who Had Previously Remitted with Escitalopram
por: Yoshimura, Reiji, et al.
Publicado: (2021)

The attention-emotion interaction in healthy female participants on oral contraceptives during 1-week escitalopram intake
por: Beinhölzl, Nathalie, et al.
Publicado: (2022)

Interaction between escitalopram and risperidone
por: Rao, Pradeep, et al.
Publicado: (2005)

Severe hyponatremia associated with escitalopram
por: Rawal, Gautam, et al.
Publicado: (2017)

Escitalopram-induced extrapyramidal symptoms
por: Kumar, Pattath Narayanan Suresh, et al.
Publicado: (2019)

Rise of escitalopram and the fall of citalopram
por: Cavanah, Luke R., et al.
Publicado: (2023)

PS85. Efficacy and Safety of Generic Escitalopram (Lexacure) in Patients with Major Depressive Disorder: A 6-week, Multi-center, Randomized, Rater-blinded, Escitalopram-comparative, Non-inferiority Study
por: Jeong, Jong-Hyun, et al.
Publicado: (2016)

Efficacy and safety of generic escitalopram versus Lexapro in the treatment of major depression: a multicenter double-blinded randomized controlled trial
por: Yu, Yimin, et al.
Publicado: (2013)

An Open-Label Rater-Blinded Randomized Trial of Vilazodone versus Escitalopram in Major Depression
por: Kumar, Pattath Narayanan Suresh, et al.
Publicado: (2022)

A pilot study on improvements in attention function in major depressive disorder after 12 weeks of escitalopram monotherapy or combined treatment with agomelatine
por: Li, Zhe, et al.
Publicado: (2023)

Preventive Effects of Escitalopram Against Anxiety-Like Depressive Behaviors in Monosodium Glutamate-Teated Rats Subjected to Partial Hepatectomy
por: Zhao, Bin-Bin, et al.
Publicado: (2019)

A 12-week Comparative Prospective Open-label Randomized Controlled Study in Depression Patients Treated with Vilazodone and Escitalopram in a Tertiary Care Hospital in North India
por: Bathla, Manish, et al.
Publicado: (2018)

Pharmacogenetically Guided Escitalopram Treatment for Pediatric Anxiety Disorders: Protocol for a Double-Blind Randomized Trial
por: Strawn, Jeffrey R., et al.
Publicado: (2021)

Hypnic jerks possibly induced by escitalopram
por: Sathe, Harshal, et al.
Publicado: (2015)

Mydriasis caused by ESCITALOPRAM: Case report
por: Bouattour, N., et al.
Publicado: (2022)

Which Patients Are Prescribed Escitalopram?: Predictors for Escitalopram Prescriptions and Functional Outcomes among Patients with Acute Ischemic Stroke
por: Kim, Jarim, et al.
Publicado: (2018)

PS89. Influence of anxiety symptoms on improvement of neurocognitive functions in patients with major depressive disorder: A 12-week, multicenter, randomized trial of tianeptine versus escitalopram, the CAMPION study
por: Kim, Kiwon, et al.
Publicado: (2016)

Dopamine Receptor D2 and Associated microRNAs Are Involved in Stress Susceptibility and Resistance to Escitalopram Treatment
por: Zhang, Yi, et al.
Publicado: (2015)

SLC39A8 is a risk factor for schizophrenia in Uygur Chinese: a case-control study
por: Jian, Xuemin, et al.
Publicado: (2019)

Comparing the Therapeutic Effects of Crocin, Escitalopram and Co-Administration of Escitalopram and Crocin on Learning and Memory in Rats with Stress-Induced Depression
por: Joodaki, Mehran, et al.
Publicado: (2021)

Serotonin and dopamine transporter availability in social anxiety disorder after combined treatment with escitalopram and cognitive-behavioral therapy
por: Hjorth, Olof, et al.
Publicado: (2022)

An Interim Analysis of a Randomized, Open-Label Study of Vilazodone, Escitalopram, or Vortioxetine for Major Depressive Disorder
por: Santi, N Simple, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_041nrrnuq4nggmj1b36gi585u0